TCIRG1 and hepatocellular carcinoma: In addition, in hepatocellular carcinoma (HCC), TCIRG1 can act as a metastasis enhancer by regulating HCC cell growth, death and epithelial–mesenchymal transition (EMT), and may also be a therapeutic target for cancer and metastasis [24].